Michael Donegan

Vice President of Finance

Michael Donegan is Vice President of Finance at TherapeuticsMD. He has served in this role since April 2013. Mr. Donegan has a 26-year background in accounting and finance. He has spent a great portion of his career focused on accounting/finance infrastructure and compliance. Mr. Donegan has spent much of the last decade designing and implementing Sarbanes-Oxley 404 compliance programs for companies of all sizes. He has also had numerous responsibilities at large public companies in corporate finance/accounting roles that include finance systems, global consolidations, and SEC reporting.

Mr. Donegan began his career at Ernst & Young, LLP, where he worked in both the audit and tax departments. Mr. Donegan has written and spoken on the topic of finance infrastructure and its impact on financial reporting, having authored Growth and Profitability: Optimizing the Finance Function for Small and Emerging Businesses (Copyright © 2002 by John Wiley and Sons, Inc. All rights reserved). Mr. Donegan earned his Bachelor of Science in Accounting and his Master of Accounting from the University of Florida.

© 2020 TherapeuticsMD, Inc. All rights reserved.